PRL and neoplasm: However, it is important to note that a significant percentage of cases with double immunostaining have normal PRL levels, as exemplified in the Rick series [95], were 27.3% of dual-staining tumor patients did not have PRL elevation and, among the hyperprolactinemic patients, 22.7% had PRL elevations below 41.5 ng/dL.